Paul Corn

Associate Professor

  • 6765 Citations
  • 37 h-Index
1989 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Paul Corn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Methylation Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
CpG Islands Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2020

1 Citation (Scopus)

Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends

Tang, C., Hoffman, K. E., Allen, P. K., Gabel, M., Schreiber, D., Choi, S., Chapin, B. F., Nguyen, Q. N., Davis, J. W., Corn, P., Logothetis, C., Ward, J., Frank, S. J., Navai, N., McGuire, S. E., Anscher, M., Pisters, L., Pettaway, C. A., Kumar, R., Linson, P. & 5 others, Tripuraneni, P., Tomaszewski, J. J., Patel, A. B., Augspurger, M. & Kuban, D. A., Feb 1 2020, In : Cancer. 126, 3, p. 506-514 9 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Delayed Diagnosis
1 Citation (Scopus)
Prostatic Neoplasms
Maximum Tolerated Dose
Area Under Curve
5 Citations (Scopus)

Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors

Shah, A. Y., Kotecha, R. R., Lemke, E. A., Chandramohan, A., Chaim, J. L., Msaouel, P., Xiao, L., Gao, J., Campbell, M. T., Zurita, A. J., Wang, J., Corn, P. G., Jonasch, E., Motzer, R. J., Sharma, P., Voss, M. H. & Tannir, N. M., Jun 2019, In : European Journal of Cancer. 114, p. 67-75 9 p.

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Blood Vessels
Clear-cell metastatic renal cell carcinoma

PARP inhibition suppresses GR-MYCN-CDK5-RB1-E2F1 signaling and neuroendocrine differentiation in castration-resistant prostate cancer

Liu, B., Li, L., Yang, G., Geng, C., Luo, Y., Wu, W., Manyam, G. C., Korentzelos, D., Park, S., Tang, Z., Wu, C., Dong, Z., Sigouros, M., Sboner, A., Beltran, H., Chen, Y., Corn, P. G., Tetzlaff, M. T., Troncoso, P., Broom, B. & 1 others, Thompson, T. C., Nov 15 2019, In : Clinical Cancer Research. 25, 22, p. 6839-6851 13 p.

Research output: Contribution to journalArticle

Glucocorticoid Receptors
Prostatic Neoplasms

Prostate Cancer: Quo Vadis?

Logothetis, C. J., Aparicio, A., Koinis, F., Corn, P. G. & Efstathiou, E., Dec 2019, In : European urology. 76, 6, p. 709-711 3 p.

Research output: Contribution to journalEditorial

Prostatic Neoplasms